Please assess the completion status of the following clinical trial:

Trial Title: Secretin Activates Human Brown Fat and Induces Satiation.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* healthy normal weight~Exclusion Criteria:~* cardiovascular disease, diabetes~* smoking

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Secretin study (Type: EXPERIMENTAL): PET and MRI scannings will be performed twice. Subjects will be given secretin hydrochloride and placebo on separate days. In addition, subjects will undergo cold exposure PET scanning once.

Based on this trial design, predict the completion outcome and termination type (if applicable).